FDA approves Pfizer's new nasal spray treatment for migraines

SCIENCE PHOTO LIBRARY/Getty Images (WASHINGTON) — The U.S. Food and Drug Administration has approved Pfizer’s newest drug on the migraine market, Zavzpret (zavegepant) — the first and only migraine treatment of its kind to be offered in